Lestaurtinib

From Wikipedia, the free encyclopedia

Lestaurtinib
Systematic (IUPAC) name
 ?
Identifiers
CAS number  ?
ATC code  ?
PubChem 126565
Chemical data
Formula C26H21N3O4 
Mol. mass 439.462 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Lestaurtinib (rINN, codenamed CEP-701) is a tyrosine kinase inhibitor undergoing research for the treatment of acute myelogenous leukemia (AML) and myeloproliferative disorders. It is an analog of staurosporine.

As of 2008, it is currently in Phase III clinical trials for AML and Phase II clinical trials for myeloproliferative disorders. [1]

It is being developed by Cephalon.

[edit] References